Add BrightSurf on Google Email

New target to beat cancer drug resistance

University of Queensland researchers have identified a novel molecule that could overcome cancer drug resistance and prevent tumour regrowth in cancer patients. The newly discovered molecule is not currently a target for treatment, opening the potential for new drug development to combat this major cause of death in cancer patients.

SourceUniversity of Queensland·JournalDrug Resistance Updates·TypeExperimental study·DateSep 21, 2023

CityU researchers develop novel photo-oxidation therapy for anticancer treatment

Researchers at City University of Hong Kong have developed a new class of near-infrared-activated photo-oxidants that can effectively kill cancer cells without requiring oxygen. The discovery offers a promising direction for developing anti-cancer drugs and could overcome existing limitations of photodynamic therapies.

SourceCity University of Hong Kong·JournalNature Chemistry·TypeExperimental study·DateSep 20, 2023

A free online tool can help prostate cancer patients save on out-of-pocket drug costs

A free online tool can help prostate cancer patients save thousands of dollars in out-of-pocket drug costs by comparing Medicare Part D prescription plans. The Medicare Part D Plan Finder identifies significant savings for patients taking abiraterone or enzalutamide, two common prescription drugs for advanced prostate cancer.

SourceMichigan Medicine - University of Michigan·JournalUrology Practice·TypeData/statistical analysis·DateSep 5, 2023

‘Meta-synergy’ for the battle against cancer

Researchers at Technion-Israel Institute of Technology developed an AI tool to identify powerful drug combinations that significantly enhance cancer treatment. The 'meta-synergy' approach uses artificial intelligence and text mining to find optimal pairs of drugs, resulting in highly effective nanomedicines with fewer side effects.

SourceTechnion-Israel Institute of Technology·JournalJournal of Controlled Release·TypeMeta-analysis·DateSep 5, 2023

Why breast cancer survivors don't take their medication, and what can be done

Breast cancer survivors often struggle to take their life-extending medication due to side effects and high costs. A new study found that interventions such as cost-cutting policies, mobile apps, and psychological counseling can increase medication adherence by nearly 1.5 times. Addressing mental health issues, particularly depression,...

SourceUniversity of Colorado at Boulder·JournalJournal of Clinical Oncology·TypeLiterature review·DateSep 1, 2023

Antioxidants stimulate blood flow in tumors

Researchers found that antioxidants activate a mechanism forming new blood vessels in tumor cells, which can help them grow and spread. The study suggests that dietary supplements containing antioxidants may accelerate tumour growth and metastasis in cancer patients.

SourceKarolinska Institutet·JournalJournal of Clinical Investigation·TypeExperimental study·DateAug 31, 2023

Gene therapy for brain tumor shows promising early results in humans

A new study from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival for patients with gliomas, a highly aggressive form of brain cancer. The treatment improved survival...

SourceMichigan Medicine - University of Michigan·JournalThe Lancet Oncology·TypeRandomized controlled/clinical trial·DateAug 31, 2023

Study sheds light on why breast cancer survivors don’t take their medications, and what can be done about it

A new study finds that cost-cutting policy changes, mobile apps, and psychological strategies can increase medication adherence by nearly 1.5 times among breast cancer survivors. The study also highlights the importance of managing side effects through physical therapy, exercise, and behavioral counseling.

SourceUniversity of Colorado at Boulder·JournalJournal of Clinical Oncology·DateAug 29, 2023

Medications for chronic diseases affect the body’s ability to regulate body temperature, keep cool

Chronic disease medications impair the body's ability to regulate core temperature, increasing the risk of heat-related illness in elderly patients. Exercise and improved fitness levels can help mitigate these effects, but bodily impairments from chemotherapy and medications may limit exercise capacity.

SourceNational University of Singapore, Yong Loo Lin School of Medicine·JournalPharmacological Reviews·TypeObservational study·DateAug 16, 2023

Many expensive cancer drugs have unclear patient benefit

A study by the University of Gothenburg found that many expensive cancer drugs have unclear patient benefits, with only one drug showing both increased life expectancy and improved quality of life. The researchers emphasize the need for further discussions on drug approvals to ensure effective use of limited healthcare resources.

SourceUniversity of Gothenburg·JournalClinical Drug Investigation·TypeData/statistical analysis·DateAug 15, 2023

New Journal of Pharmaceutical Analysis articles showcase promising therapeutic candidates for treating cancer and hearing loss

Researchers developed innovative techniques to treat challenging cancers and manage therapy side effects. Inhibitors targeting PRMT5, a histone-modifying enzyme, alleviated cisplatin-induced hearing loss, while nano-pills delivered combination drugs to liver cancer cells.

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateAug 8, 2023

New technology promises rapid and reliable development of new diagnostic tests

Researchers at Queensland University of Technology have developed a new approach to designing molecular ON-OFF switches based on proteins, which can be used in various biotechnological and biomedical applications. The novel technique allows for faster and more accurate diagnostic tests for detecting diseases and monitoring water quality.

SourceQueensland University of Technology·JournalNature Nanotechnology·TypeExperimental study·DateJul 27, 2023

Journal of Pharmaceutical Analysis studies make advances in spatiotemporal pharmacometabolomics, plasma proteome profiling, and hepatocellular carcinoma therapeutics

Researchers developed new methods for detecting drug-induced hepatotoxicity using 3D cell cultures and mass spectrometry imaging, identifying biomarkers and effective interventions. A zeolite-based protein corona method was also used to characterize plasma proteins, enabling the identification of low-abundance proteins and their potent...

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateJul 26, 2023

Team from Korea University medicine explores ways to overcome cisplatin resistance and alleviate pain in cancer treatment

Researchers from Korea University Medicine have discovered a potential therapeutic target for overcoming cisplatin resistance and neuropathic pain in cervical cancer. By inhibiting TRPV1, they found that resistant tumors became vulnerable to cisplatin, improving the outlook for patients.

SourceKorea University College of Medicine·JournalNature Communications·TypeExperimental study·DateJul 20, 2023

Approved drug could help overcome resistance to primary treatment against metastatic breast cancer

Researchers have discovered a mechanism leading to resistance in luminal breast cancer and propose using the approved osteoporosis drug denosumab to block RANK protein, promoting effectiveness of CDK4/6 inhibitors. This could lead to new treatment options for patients with metastatic breast cancer.

SourceCentro Nacional de Investigaciones Oncológicas (CNIO)·JournalCell Reports Medicine·TypeExperimental study·DateJul 14, 2023

HKUMed in collaboration with the Hong Kong Sanatorium & Hospital, establishes the positive clinical impact of the Multidisciplinary Molecular Tumour Board among patients with advanced solid cancer in the era of Precision Cancer Medicine

The Multidisciplinary Molecular Tumour Board (MTB) has been shown to improve treatment response rates for patients with advanced solid cancer, with 64% of patients benefiting from the MTB-guided approach. The board provides a systematic precision oncology strategy for treatment selection, combining expertise in multiple disciplines.

SourceThe University of Hong Kong·JournalThe Lancet Regional Health - Western Pacific·TypeExperimental study·DateJul 4, 2023

Innovative stem cell research takes aim at origins of human cancers

A collaborative study by researchers at the University of Ottawa and McMaster University has made a groundbreaking discovery linking different types of cancers to their embryonic origins. The team found that drugs targeting specific embryonic pathways can effectively treat various tumors, including brain, colon, and leukemia cancers.

SourceUniversity of Ottawa·JournalCell Chemical Biology·TypeData/statistical analysis·DateJun 28, 2023

New Journal of Pharmaceutical Analysis articles showcase innovative approaches for diagnostics and drug screening and evaluation

Recent studies in the New Journal of Pharmaceutical Analysis feature novel diagnostic tools, RNA sequencing-based workflows, and mechanical property evaluations to enhance cancer and cardiovascular disease treatment outcomes. These innovations aim to improve the therapeutic effect of drugs and promote personalized medicine.

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateJun 21, 2023

A patient with kidney cancer overcomes several metastases against all expectations. CNIO researchers discover why and pave the way for similar cases

A patient with kidney cancer overcame several metastases with temsirolimus, leading researchers to identify key mutations that make this treatment effective. The study found that patients with USP9X mutations have altered autophagy and respond better to temsirolimus.

SourceCentro Nacional de Investigaciones Oncológicas (CNIO)·JournalInternational Journal of Cancer·TypeExperimental study·DateJun 14, 2023

New way of identifying proteins supports drug development

Researchers have developed a new way to identify proteins based on their amino acid content, which can predict protein function and facilitate the development of new biological drugs. The method shows promise in cancer research, where it can help design more targeted treatments by linking survivin and PRC2 proteins.

SourceUniversity of Gothenburg·JournaliScience·TypeComputational simulation/modeling·DateJun 14, 2023